Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 contact hours.

Acknowledgment of Support

This activity is supported by educational grants from Kite Pharma, Inc. and Legend Biotech USA, Inc.

Community Practice Connections™: CAR T Preconference Workshop at the PER® Winter Hematology® Meeting

Release Date: April 09, 2021
Expiration Date: April 09, 2022

Activity Overview

Community Practice Connections™: CAR T Preconference Workshop at the PER® Winter Hematology® Meeting consists of a series of short summaries of clinical data and concise video interviews with leading experts in chimeric antigen receptor (CAR) T-cell therapy for patients with hematologic malignancies. The video interviews provide expert perspectives on clinical data and address questions commonly faced in the community oncology practice setting.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Kite Pharma, Inc. and Legend Biotech USA, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the mechanism of action and specificities of CAR T cells as living therapeutics
  • Assess clinical data from landmark trials evaluating CAR T-cell therapies in hematologic malignancies
  • Implement proactive strategies to recognize and minimize the impact of CAR T-cell–related toxicities on patients with hematologic tumors
  • Evaluate the therapeutic implications of emerging clinical data on CAR T-cell therapies within the context of evolving treatment paradigms for hematologic cancers

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Faculty

Andre H. Goy, MD
Andre H. Goy, MD
Physician in Chief Hackensack Meridian Health
Oncology Care Transformation Service
Chairman & Chief Physician Officer - John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology - Hackensack Meridian School of Medicine
Professor of Medicine - Georgetown University
Hackensack, NJ

Disclosures: Grant/Research Support: PI: Acerta Pharma, AstraZeneca, Celgene Corporation, Constellation Pharmaceuticals, Inc, Genentech-F. Hoffmann-La Roche Ltd, Infinity Pharmaceuticals, Inc, Infinity Pharmaceuticals, Inc-Verastem Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson, Karyopharm Therapeutics Inc, Kite, a Gilead Company, Pharmacyclics, Inc; Consultant: Acerta Pharma, Celgene Corporation, Gilead Sciences, Janssen Pharmaceutical Companies of Johnson & Johnson, Kite, a Gilead Company, Xcenda; Shareholder: COTA; Other: Honoraria: AstraZeneca, Celgene Corporation, Kite, a Gilead Company, Xcenda; Advisory: AstraZeneca, COTA, Gilead Sciences, Inc, Janssen Pharmaceutical Companies of Johnson & Johnson, Kite, a Gilead Company.

Stephan Grupp, MD, PhD
Stephan Grupp, MD, PhD
Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine
Chief, Cellular Therapy and Transplant Section
Director, Cancer Immunotherapy Program
Children’s Hospital of Philadelphia
Philadelphia, PA

Disclosures: Grant/Research Support: Kite Pharma, Novartis Pharmaceuticals, Servier Laboratories; Consultant: Cellular Biomedicine Group, GlaxoSmithKline, Hoffmann-La Roche, Humanigen, Janssen/Johnson & Johnson, Novartis Pharmaceuticals; Other: SSC or SAB for: Adaptimmune Therapeutics, Allogene Therapeutics, Cabaletta Bio, Cellectis, Jazz Pharmaceuticals, Juno Therapeutics, Novartis Pharmaceuticals, TCR2 Therapeutics, Vertex Pharmaceuticals.

Nina Shah, MD
Nina Shah, MD
Associate Professor, Department of Medicine
UCSF Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA

Disclosures: Grant/Research Support: bluebird bio, Celgene/Bristol Myers Squibb, Janssen, Nektar Therapeutics, Poseida Therapeutics, Sutro Biopharma, TeneoBio; Consultant: Amgen, Bristol Myers Squibb, CareDx, GlaxoSmithKline, Indapta Therapeutics, Karyopharm Therapeutics, Kite, Sanofi.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By